Navigation Links
Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
Date:9/14/2009

MONMOUTH JUNCTION, N.J., Sept. 14 /PRNewswire/ -- Transave, Inc., today reported positive results from a Phase II clinical trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation). The Phase II data indicated that ARIKACE, delivered once daily for 28 consecutive days, demonstrated superior clinical benefit compared to placebo as measured by patient and physician reported outcomes and reduction in Pseudomonas aeruginosa density. In addition, ARIKACE was well-tolerated with overall adverse events comparable to placebo. Results were presented today at the European Respiratory Society Meeting in Vienna, Austria by Anne E. O'Donnell, MD, Professor of Medicine and Chief of the Division of Pulmonary, Critical Care and Sleep Medicine, Georgetown University Hospital, and co-lead investigator of the study.

The double-blind, placebo-controlled study was designed to evaluate ARIKACE in non-CF patients who have bronchiectasis with Pseudomonas lung infections. Sixty-four adult patients were randomized to receive ARIKACE - either 280 mg or 560 mg daily dosages - or placebo. Patients received 28 days of therapy followed by a 28-day off-treatment observation period. ARIKACE and placebo were administered once daily using an eFlow (R) Nebulizer System (PARI Pharma GmbH), a novel, highly efficient, portable aerosol delivery system. Sixteen clinical sites throughout Europe and India participated in the study.

"The positive efficacy and tolerability profile demonstrated by ARIKACE in this study is encouraging for non-CF bronchiectasis patients that have pseudomonas lung infections and for physicians who treat them," said Dr. O'Donnell. "These successful results with ARIKACE are especially important since there is nothing currently approved to treat bronchiectasis patients with these types of infections."'/>"/>

SOURCE Transave, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
2. Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
3. Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV
4. Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
5. ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
6. BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury
7. DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
8. BioSpecifics Technologies Corp. Announces XIAFLEX(TM) CORD I Study Published in New England Journal of Medicine
9. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
10. Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
11. Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ... commercialization of proprietary compounded drug therapies, today reported that ... 2014 financial results on Thursday, March 12, 2015.  The ... EDT (1:30 p.m. PDT) on the same day to ... activities.  The conference call and webcast will be open ...
(Date:3/4/2015)... Perrigo Company plc (NYSE: PRGO ; TASE) today ... Papa will present at the 2015 Barclays Global Healthcare ... the Loews Miami Beach Hotel in Miami, FL. ... http://perrigo.investorroom.com/events-webcasts . From its beginnings as a ... headquartered in Ireland , has grown to ...
(Date:3/4/2015)... 2015  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) ... ROTH Conference at the Ritz-Carlton at Laguna Niguel, ... PT, Arthur S. Przybyl , President and CEO, will ... section of ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s ... archived and available through the link through June 7, 2015. ...
Breaking Medicine Technology:Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 2Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 3Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2
... Scientific Corporation (NYSE: BSX ) will webcast its conference ... 30, 2009 on Tuesday, October 20, at 8:00 a.m. ET. ... and Chief Executive Officer, and Sam Leno, Executive Vice President ... replay of this call will be available at ...
... ... Services will pay the United States $1.375 million to resolve False ... the guise of a sham durable medical equipment (DME) provider, the ... its affiliate MediNet Corp. provided the kickbacks and assistance and, in ...
Cached Medicine Technology:Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 2Harborside Healthcare to Pay U.S. $1.375 Million to Resolve Allegations of Kickbacks and Sham Durable Medical Services 2
(Date:3/4/2015)... Alliance Healthcare Foundation (AHF), a non-profit ... in need in San Diego and Imperial Counties, announced ... Mission Support Grants program with awards totaling $1 million. ... AHF’s Mission Support Grants program. Grant recipients were chosen ... and program committee, as well as the community as ...
(Date:3/4/2015)... The Global Liquefied Petroleum Gas ... and is estimated to grow to $288.7 billion ... 2014 to 2019. , Browse through the TOC ... analysis of industry trends, segments & forecasts., ... gas market is classified into source, application, and ...
(Date:3/4/2015)... RapidScale, a global cloud services innovator, is attending ... 16th-18th. They are hosting Booth #1010 on the expo ... engineering executives in attendance to provide demos and discuss ... include William Hiatt, CTO; Jeff Richards, Cloud Delivery Manager; ... Support Manager. , RapidScale is also hosting two ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 According to ... millions of people in the U.S. suffer from gastroesophageal ... Medications are commonly prescribed to control acid production, but ... procedures can overly correct the problem and lead to ... Opportunity, GERD occurs when the lower esophageal sphincter does ...
(Date:3/4/2015)... The Conrad N. Hilton Foundation has ... $6.9 million, which will help 151,000 people access safe, ... , The programs cover three years and the investment ... fixing water points in disrepair, addressing water quality ... maintain water points and ensuring safe water supplies for ...
Breaking Medicine News(10 mins):Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 3Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 2Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 3Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4
... for their effects on fat development, researchers have discovered ... in mice without some of the side effects ... they pinpointed, known as harmine, was first isolated more ... ritual and medicinal preparations around the world, the team ...
... and neglect of young children in military families in Texas ... at Chapel Hill study shows, raising concerns about the impact ... the country. ,The study, published in the ... was designed by UNC School of Public Health researchers to ...
... imported fire ants (RIFAs), which have caused trouble in ... Virginia. Colonies of the tiny, highly aggressive insects have ... in recent years, have caught the attention of Virginia ... the increasing number of fire ant infestations. ...
... 800 poultry farms in the capital following an outbreak of ... Saturday. ,The deadly H5N1 bird flu ... two other farms the next day in Chak Shehzad, a ... Usmani. ,Several thousand chickens were killed by the ...
... 30 seconds, it rivals HIV and tuberculosis as the world's ... are under five years old. Now, just over 100 years ... Prize for finally proving that malaria is transmitted by mosquitoes, ... a significant breakthrough in the search for an effective vaccine. ...
... specific antigen (PSA) levels is the most significant predictor of ... published in the journal Cancer. ,The study ... (PSA Velocity) is more than 2 ng/ml/year, it is an ... ,According to the researchers, the new findings attain ...
Cached Medicine News:Health News:Fat Screen Delivers Plant-derived Chemical With Antidiabetic Effects 2Health News:Stress of Deployment Increases Risk of Child Abuse, Neglect in Military Families, UNC Study Shows 2Health News:Stress of Deployment Increases Risk of Child Abuse, Neglect in Military Families, UNC Study Shows 3Health News:Fire Ants are Emerging Nuisance for Virginians 2Health News:Fire Ants are Emerging Nuisance for Virginians 3Health News:Vaccine Hope for Malaria 2Health News:Scientists Identify the Most Significant Single Predictor of Aggressive Prostate Cancer 2
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: